Randall Stanicky
Chief Financial Officer,
Click Therapeutics
Mr. Stanicky currently serves as the Chief Financial Officer for Click Therapeutics, a company focused on bringing digital and software enhanced drugs to the market. At Click Therapeutics he has led multiple capital raises while scaling the company and is a regular speaker at Wall Street conferences on behalf of the company. Prior to joining Click Therapeutics he spent more than 20-years on Wall Street as an equity analyst, most recently serving as Managing Director, Global Equity Research at RBC Capital Markets where he was most recently ranked number 2 by Institutional Investor within the Specialty Pharmaceuticals coverage. Prior to RBC Capital Markets, Mr. Stanicky spent over 10 years at Goldman Sachs leading research teams across multiple sectors within healthcare where he was also a regular speaker at global industry conferences and regularly quoted across a variety media platforms including the Wall Street Journal, CNBC, Bloomberg among others.
Mr. Stanicky is currently a contributing Editor of Finance and Digital Technology for Endeavor Venture Fund and Venture Studio and Founding Member of The F Suite, an invite-only peer community of CFO’s. He is also an Honorary Board member of the Children’s Tumor Foundation where he headed the Audit Committee and Co-Chaired the Business Advisory Committee and previously sat on the Board member of TherapeuticsMD (NASDAQ: TXMD).
Mr. Stanicky is currently a contributing Editor of Finance and Digital Technology for Endeavor Venture Fund and Venture Studio and Founding Member of The F Suite, an invite-only peer community of CFO’s. He is also an Honorary Board member of the Children’s Tumor Foundation where he headed the Audit Committee and Co-Chaired the Business Advisory Committee and previously sat on the Board member of TherapeuticsMD (NASDAQ: TXMD).